scholarly journals The Effect of Modified Constraint-Induced Movement Therapy on Upper Extremity Function of a Patient With Severe Acquired Brain Injury

2020 ◽  
pp. 106-119
Author(s):  
Shiva Abedi ◽  
Nazila Akbarfahimi
Keyword(s):  
Brain Injury ◽  
Upper Extremity ◽  
Acquired Brain Injury ◽  
Movement Therapy ◽  
Constraint Induced Movement Therapy ◽  
Extremity Function ◽  
Severe Acquired Brain Injury ◽  
Upper Extremity Function

scholarly journals Application of Combined Botulinum Toxin Type A and Modified Constraint-Induced Movement Therapy for an Individual With Chronic Upper-Extremity Spasticity After Stroke

2006 ◽  
Vol 86 (10) ◽  
pp. 1387-1397 ◽  
Author(s):  
Shu-Fen Sun ◽  
Chien-Wei Hsu ◽  
Chiao-Wen Hwang ◽  
Pei-Te Hsu ◽  
Jue-Long Wang ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Upper Extremity ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Movement Therapy ◽  
Botulinum Toxin Type ◽  
Constraint Induced Movement Therapy ◽  
Extremity Function ◽  
Severe Spasticity ◽  
Upper Extremity Function

Abstract Background and Purpose. Constraint-induced movement therapy (CIMT) is a promising intervention for retraining upper-extremity function after a stroke. The purpose of this case report is to describe the use of a combination of botulinum toxin type A (BtxA) and a modified CIMT program for a patient with severe spasticity who was unable to use his right upper extremity. Case Description. The 52-year-old patient, who had a stroke 4 years ago, did not meet the minimum motor criteria for CIMT benefit. After receiving BtxA injections targeting the elbow, wrist, and finger flexors, he completed a 4-week program of modified CIMT followed by a 5-month home exercise program. Outcomes. The patient exhibited improvement in muscle tone (the velocity-dependent resistance to stretch that muscle exhibits) and in scores on several upper-extremity function tests (Modified Ashworth Scale, Motor Activity Log, Wolf Motor Function Test, Action Research Arm Test, and Fugl-Meyer Assessment of Motor Recovery). He also reported making much progress in the functional use of the involved upper extremity. Discussion. In a patient with severe flexor spasticity and nonuse of the dominant upper extremity after a stroke, a combined treatment of BtxA and modified CIMT may have resulted in improved upper-extremity use.

Sign in / Sign up

Export Citation Format

Share Document